Your browser doesn't support javascript.
loading
Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations: A Review.
Hua, Le H; Solomon, Andrew J; Tenembaum, Silvia; Scalfari, Antonio; Rovira, Àlex; Rostasy, Kevin; Newsome, Scott D; Marrie, Ruth Ann; Magyari, Melinda; Kantarci, Orhun; Hemmer, Bernhard; Hemingway, Cheryl; Harnegie, Mary Pat; Graves, Jennifer S; Cohen, Jeffrey A; Bove, Riley; Banwell, Brenda; Corboy, John R; Waubant, Emmanuelle.
Afiliação
  • Hua LH; Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, Nevada.
  • Solomon AJ; Larner College of Medicine at the University of Vermont, Burlington.
  • Tenembaum S; Department of Neurology, National Pediatric Hospital Dr J. P. Garrahan, Buenos Aires, Argentina.
  • Scalfari A; Centre for Neuroscience, Department of Medicine, Charing Cross Hospital, Imperial College London, London, United Kingdom.
  • Rovira À; Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Rostasy K; Children's Hospital Datteln, University Witten/Herdecke, Witten, Germany.
  • Newsome SD; Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Marrie RA; Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Magyari M; Danish Multiple Sclerosis Center, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Kantarci O; Department of Neurology, Mayo Clinic, Rochester, Minnesota.
  • Hemmer B; Department of Neurology, Technical University of Munich, Munich, Germany.
  • Hemingway C; Munich Cluster for Systems Neurology, Munich, Germany.
  • Harnegie MP; Paediatric Neurology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Graves JS; Institute of Neurology, University College London, London, United Kingdom.
  • Cohen JA; Cleveland Clinic Libraries, Cleveland Clinic, Cleveland, Ohio.
  • Bove R; Department of Neurosciences, University of California, San Diego.
  • Banwell B; Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio.
  • Corboy JR; UCSF Weill Institute for Neurosciences, University of California, San Francisco.
  • Waubant E; Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
JAMA Neurol ; 2024 Sep 16.
Article em En | MEDLINE | ID: mdl-39283621
ABSTRACT
Importance While the typical onset of multiple sclerosis (MS) occurs in early adulthood, 2% to 10% of cases initially present prior to age 18 years, and approximately 5% after age 50 years. Guidance on approaches to differential diagnosis in suspected MS specific to these 2 age groups is needed. Observations There are unique biological factors in children younger than 18 years and in adults older than age 50 years compared to typical adult-onset MS. These biological differences, particularly immunological and hormonal, may influence the clinical presentation of MS, resilience to neuronal injury, and differential diagnosis. While mimics of MS at the typical age at onset have been described, a comprehensive approach focused on the younger and older ends of the age spectrum has not been previously published. Conclusions and Relevance An international committee of MS experts in pediatric and adult MS was formed to provide consensus guidance on diagnostic approaches and key clinical and paraclinical red flags for non-MS diagnosis in children and older adults.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAMA Neurol Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAMA Neurol Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos